Asset
LX-7101
Lexicon Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01528111 | phase1_2 | completed | 2012-03-01 | 2012-06-01 | Lexicon Pharmaceuticals | Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension |
FDA applications (0)
This company has no applications containing this asset.